Bragar Eagel & Squire, P.C. is Investigating the Board of Directors of Mazor Robotics Ltd. (MZOR) on Behalf of Stockholders and Encourages MZOR Investors to Contact the Firm
NEW YORK, Sept. 21, 2018 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C. is investigating potential claims against Mazor Robotics Ltd. (MZOR) on behalf of stockholders concerning the proposed acquisition of the company by Medtronic plc (MDT).
Pursuant to the proposed transaction, announced on September 21, 2018 and valued at $1.64 billion, Mazor stockholders will receive $58.50 in cash for each American Depository share and $29.25 for each ordinary share of Mazor common stock owned. The investigation focuses on whether Mazor and its board of directors violated the federal securities laws and/or breached their fiduciary duties to the Company’s stockholders by failing to conduct a fair process and whether and by how much the proposed transaction undervalues the Company.
If you own Mazor shares, have information, would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Brandon Walker or Melissa Fortunato by email at firstname.lastname@example.org, or telephone at (212) 308-1869, or by filling out this contact form. There is no cost or obligation to you.
Bragar Eagel & Squire, P.C. is a New York-based law firm concentrating in commercial and securities litigation. For additional information concerning our investigation of Mazor Robotics Ltd. please go to https://bespc.com/mazor/. For additional information about Bragar Eagel & Squire, P.C. please go to www.bespc.com.